Purple Biotech Ltd. American Depositary Shares

Purple Biotech will present new preclinical data on its CAPTN-3 platform of conditionally activated tri-specific antibodies at the ESMO Immuno-Oncology 2025 Congress, showcasing potential advances in cancer treatment targeting tumor immune evasion and drug resistance.

Purple Biotech Ltd. Sponsored ADR (PPBT) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares rose 62.8% to $0.6841 in pre-market trading...